Global Respiratory Syncytial Virus Diagnostic Market

Global Respiratory Syncytial Virus (RSV) Diagnostic Market Key Players Competitive Survey Report 2023

Global Respiratory Syncytial Virus Diagnostic Market

Global Respiratory Syncytial Virus (RSV) Diagnostic Market Key Players Competitive Survey Report 2023


Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.


Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global Respiratory Syncytial Virus (RSV) Diagnostic market size in 2022 is 923.1 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 10.91% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Respiratory Syncytial Virus (RSV) Diagnostic market include BIOMERIEUX (France), BD (U.S.), Abbott (U.S.), F. Hoffman La. Roche Ltd (Switzerland), and Danaher (U.S.). The share of the top 3 players in the Respiratory Syncytial Virus (RSV) Diagnostic market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Respiratory Syncytial Virus (RSV) Diagnostic market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Kits and Assays accounted for XX% of Respiratory Syncytial Virus (RSV) Diagnostic market in 2022. Instruments share of XX%.

Hospitals and Clinics accounted for XX% of the Respiratory Syncytial Virus (RSV) Diagnostic market in 2022. Clinical Laboratories accounts for XX%.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

COVID-19 Impact:

Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Respiratory Syncytial Virus (RSV) Diagnostic market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.

The report analyzes the key trends in each segment of the global Respiratory Syncytial Virus (RSV) Diagnostic market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.

Key benefits to stakeholders:

The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Respiratory Syncytial Virus (RSV) Diagnostic market for 2017-2028.

The research report provides the latest information on the market drivers, challenges and opportunities of the global Respiratory Syncytial Virus (RSV) Diagnostic market.

The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.

Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Respiratory Syncytial Virus (RSV) Diagnostic industry and its attractiveness.

The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Market Data Breakdown by Regions

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Spain

Nordic

Asia Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Egypt

South Africa

UAE

Turkey

Saudi Arabia

Some prominent players in the market includes:

BIOMERIEUX (France)

BD (U.S.)

Abbott (U.S.)

F. Hoffman La. Roche Ltd (Switzerland)

Danaher (U.S.)

Thermo Fisher Scientific Inc. (U.S.)

Luminex Corporation (U.S.)

BioCartis, Hologic, Inc. (U.S.)

Fast Track Diagnostics Luxembourg S.à r.l. (Luxembourg)

Beckman Coulter Inc. (U.S.)

Ortho-Clinical Diagnostics (U.S.)

Bio-Rad Laboratories Inc. (U.S.)

DiaSorin S.p.A. (Italy)

Market Data Breakdown by Type

Kits and Assays

Instruments

Others

Market Data Breakdown by Applications

Hospitals and Clinics

Clinical Laboratories

Others

Table of Content

1 Respiratory Syncytial Virus (RSV) Diagnostic Market Introduction and Overview

1.1 Respiratory Syncytial Virus (RSV) Diagnostic Definition

1.2 Research Purposes

1.3 Report Timeline

1.4 Economic Analysis of Global Regions

1.5 Inflation Analysis

1.6 The Impact of the Russian-Ukrainian War on the Market

1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global

2 Global Respiratory Syncytial Virus (RSV) Diagnostic Historical Market Analysis by Type

2.1 Market Size Analysis by Types

2.2 Global Respiratory Syncytial Virus (RSV) Diagnostic Revenue and Market Share by Type

3 Global Respiratory Syncytial Virus (RSV) Diagnostic Historical Market Analysis by Application

3.1 Market Size Analysis by Application

3.2 Global Respiratory Syncytial Virus (RSV) Diagnostic Revenue Market Share by Application (2018-2023)

4 Global Market Growth Trends Analysis

4.1 Global Respiratory Syncytial Virus (RSV) Diagnostic Market Size (2018-2023)

4.2 Respiratory Syncytial Virus (RSV) Diagnostic Growth Trends Analysis by Regions

4.2.1 Respiratory Syncytial Virus (RSV) Diagnostic Market Size by Regions: 2018 VS 2023 VS 2029

4.2.2 Respiratory Syncytial Virus (RSV) Diagnostic Historic Revenue Market Size by Regions (2018-2023)

4.2.3 North America Respiratory Syncytial Virus (RSV) Diagnostic Market Size (2018-2023)

4.2.4 Europe Respiratory Syncytial Virus (RSV) Diagnostic Market Size (2018-2023)

4.2.5 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostic Market Size (2018-2023)

4.2.6 Latin America Respiratory Syncytial Virus (RSV) Diagnostic Market Size (2018-2023)

4.2.7 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostic Market Size (2018-2023)

5 North America

5.1 North America Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries

5.1.1 North America Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries (2018-2023)

5.2 North America Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Types

5.3 North America Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Applications

5.4 United States

5.5 Canada

6 Asia Pacific

6.1 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries

6.1.1 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries (2018-2023)

6.2 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Types

6.3 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Applications

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries

7.1.1 Europe Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries (2018-2023)

7.2 Europe Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Types

7.3 Europe Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Applications

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Nordic

8 Latin America

8.1 Latin America Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries

8.1.1 Latin America Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries (2018-2023)

8.2 Latin America Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Types

8.3 Latin America Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Applications

8.4 Brazil

8.5 Argentina

8.6 Mexico

9 Middle East & Africa

9.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries

9.1.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Countries (2018-2023)

9.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Types

9.3 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostic Revenue by Applications

9.4 Egypt

9.5 South Africa

9.6 UAE

9.7 Turkey

9.8 Saudi Arabia

10 Global Respiratory Syncytial Virus (RSV) Diagnostic Market Competition, by Players

10.1 Global Respiratory Syncytial Virus (RSV) Diagnostic Revenue and Market Share by Players

10.2 Market Concentration Rate

10.2.1 Top 3 Respiratory Syncytial Virus (RSV) Diagnostic Players Market Share in 2022

10.2.2 Top 6 Respiratory Syncytial Virus (RSV) Diagnostic Players Market Share in 2022

10.2.3 Market Competition Trend

10.3 Respiratory Syncytial Virus (RSV) Diagnostic Players Head Office, Business Provided

10.4 Respiratory Syncytial Virus (RSV) Diagnostic Mergers & Acquisitions

10.5 Respiratory Syncytial Virus (RSV) Diagnostic New Entrants and Expansion Plans

11 Players Profiles11.1 BIOMERIEUX (France)

11.1.1 BIOMERIEUX (France) Company Profile

11.1.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.1.3 BIOMERIEUX (France) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.1.4 BIOMERIEUX (France) Business Overview

11.1.5 Recent Developments and Plans

11.2 BD (U.S.)

11.2.1 BD (U.S.) Company Profile

11.2.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.2.3 BD (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.2.4 BD (U.S.) Business Overview

11.2.5 Recent Developments and Plans

11.3 Abbott (U.S.)

11.3.1 Abbott (U.S.) Company Profile

11.3.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.3.3 Abbott (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.3.4 Abbott (U.S.) Business Overview

11.3.5 Recent Developments and Plans

11.4 F. Hoffman La. Roche Ltd (Switzerland)

11.4.1 F. Hoffman La. Roche Ltd (Switzerland) Company Profile

11.4.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.4.3 F. Hoffman La. Roche Ltd (Switzerland) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.4.4 F. Hoffman La. Roche Ltd (Switzerland) Business Overview

11.4.5 Recent Developments and Plans

11.5 Danaher (U.S.)

11.5.1 Danaher (U.S.) Company Profile

11.5.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.5.3 Danaher (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.5.4 Danaher (U.S.) Business Overview

11.5.5 Recent Developments and Plans

11.6 Thermo Fisher Scientific Inc. (U.S.)

11.6.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile

11.6.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.6.3 Thermo Fisher Scientific Inc. (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.6.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview

11.6.5 Recent Developments and Plans

11.7 Luminex Corporation (U.S.)

11.7.1 Luminex Corporation (U.S.) Company Profile

11.7.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.7.3 Luminex Corporation (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.7.4 Luminex Corporation (U.S.) Business Overview

11.7.5 Recent Developments and Plans

11.8 BioCartis, Hologic, Inc. (U.S.)

11.8.1 BioCartis, Hologic, Inc. (U.S.) Company Profile

11.8.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.8.3 BioCartis, Hologic, Inc. (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.8.4 BioCartis, Hologic, Inc. (U.S.) Business Overview

11.8.5 Recent Developments and Plans

11.9 Fast Track Diagnostics Luxembourg S.à r.l. (Luxembourg)

11.9.1 Fast Track Diagnostics Luxembourg S.à r.l. (Luxembourg) Company Profile

11.9.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.9.3 Fast Track Diagnostics Luxembourg S.à r.l. (Luxembourg) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.9.4 Fast Track Diagnostics Luxembourg S.à r.l. (Luxembourg) Business Overview

11.9.5 Recent Developments and Plans

11.10 Beckman Coulter Inc. (U.S.)

11.10.1 Beckman Coulter Inc. (U.S.) Company Profile

11.10.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.10.3 Beckman Coulter Inc. (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.10.4 Beckman Coulter Inc. (U.S.) Business Overview

11.10.5 Recent Developments and Plans

11.11 Ortho-Clinical Diagnostics (U.S.)

11.11.1 Ortho-Clinical Diagnostics (U.S.) Company Profile

11.11.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.11.3 Ortho-Clinical Diagnostics (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.11.4 Ortho-Clinical Diagnostics (U.S.) Business Overview

11.11.5 Recent Developments and Plans

11.12 Bio-Rad Laboratories Inc. (U.S.)

11.12.1 Bio-Rad Laboratories Inc. (U.S.) Company Profile

11.12.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.12.3 Bio-Rad Laboratories Inc. (U.S.) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.12.4 Bio-Rad Laboratories Inc. (U.S.) Business Overview

11.12.5 Recent Developments and Plans

11.13 DiaSorin S.p.A. (Italy)

11.13.1 DiaSorin S.p.A. (Italy) Company Profile

11.13.2 Respiratory Syncytial Virus (RSV) Diagnostic Product Overview

11.13.3 DiaSorin S.p.A. (Italy) Respiratory Syncytial Virus (RSV) Diagnostic Market Performance (2018-2023)

11.13.4 DiaSorin S.p.A. (Italy) Business Overview

11.13.5 Recent Developments and Plans

12 Global Respiratory Syncytial Virus (RSV) Diagnostic Forecast Market Analysis by Type

12.1 Global Respiratory Syncytial Virus (RSV) Diagnostic Revenue Market Forecast by Type (2023-2029)

13 Global Respiratory Syncytial Virus (RSV) Diagnostic Forecast Market Analysis by Application

13.1 Respiratory Syncytial Virus (RSV) Diagnostic Revenue Market Forecast by Application (2023-2029)

14 Global Market Growth Forecast Analysis

14.1 Global Respiratory Syncytial Virus (RSV) Diagnostic Forecast Market Size (2023-2029)

14.2 Respiratory Syncytial Virus (RSV) Diagnostic Growth Trends Forecast Analysis by Regions

14.2.1 Respiratory Syncytial Virus (RSV) Diagnostic Revenue Forecast Market Size by Regions (2023-2029)

14.2.2 North America Respiratory Syncytial Virus (RSV) Diagnostic Forecast Market Size (2023-2029)

14.2.3 Europe Respiratory Syncytial Virus (RSV) Diagnostic Forecast Market Size (2023-2029)

14.2.4 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostic Forecast Market Size (2023-2029)

14.2.5 Latin America Respiratory Syncytial Virus (RSV) Diagnostic Forecast Market Size (2023-2029)

14.2.6 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostic Forecast Market Size (2023-2029)

15 Respiratory Syncytial Virus (RSV) Diagnostic Industry Dynamic Analysis

15.1 Respiratory Syncytial Virus (RSV) Diagnostic Market Trends Analysis

15.2 Respiratory Syncytial Virus (RSV) Diagnostic Market Drivers Analysis

15.3 Respiratory Syncytial Virus (RSV) Diagnostic Market Challenges Analysis

15.4 Respiratory Syncytial Virus (RSV) Diagnostic Market Restraints Analysis

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global Respiratory Syncytial Virus (RSV) Diagnostic Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the Global Respiratory Syncytial Virus (RSV) Diagnostic Market?
New players are entering the Global Respiratory Syncytial Virus (RSV) Diagnostic Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What is the market value of the Global Respiratory Syncytial Virus (RSV) Diagnostic Industry?
In 2024, the Global Respiratory Syncytial Virus (RSV) Diagnostic Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
What is really changing the Global Respiratory Syncytial Virus (RSV) Diagnostic Market behavior?
Consumer behavior changes will reshape the entire decision-making process and companies in the Global Respiratory Syncytial Virus (RSV) Diagnostic Industry will need to adapt quickly.
Who should consider the Global Respiratory Syncytial Virus (RSV) Diagnostic Market study?
The Global Respiratory Syncytial Virus (RSV) Diagnostic Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.